Naltrexone and Disturbance in attention - a phase IV clinical study of FDA data

Summary:

Disturbance in attention is reported as a side effect among people who take Naltrexone (naltrexone), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Vivitrol, and have Drug dependence.

The phase IV clinical study analyzes which people have Disturbance in attention when taking Naltrexone. It is created by eHealthMe based on reports of 4,805 people who have side effects when taking Naltrexone from the FDA, and is updated regularly.

What is Naltrexone?

Naltrexone has active ingredients of naltrexone. eHealthMe is studying from 4,833 Naltrexone users. Check the latest studies of Naltrexone.

What is Disturbance in attention?

Disturbance in attention is found to be associated with 1,772 drugs and 1,970 conditions by eHealthMe. Check the latest studies of Disturbance in attention.

On Jul, 26, 2026

4,805 people reported to have side effects when taking Naltrexone.
Among them, 30 people (0.62%) have Disturbance in attention.

Could Naltrexone cause Disturbance in attention?

Among these 30 people:

How long have people been on Naltrexone when they have Disturbance in attention? *

What is the gender of people who have Disturbance in attention when taking Naltrexone? *

female: 56.67 %
male: 43.33 %

What is the age of people who have Disturbance in attention when taking Naltrexone? *

What are other drugs people take besides Naltrexone? *

What are other side effects people have besides Disturbance in attention? *

Fatigue (feeling of tiredness): 14 people, 46.67%
Depression: 9 people, 30.00%
Weakness: 8 people, 26.67%
Dizziness: 8 people, 26.67%
Headache (pain in head): 6 people, 20.00%
Feeling Abnormal: 6 people, 20.00%
Memory Loss: 6 people, 20.00%
Nausea (feeling of having an urge to vomit): 6 people, 20.00%
Pain: 5 people, 16.67%
Confusional State: 5 people, 16.67%

What are the existing conditions these people have? *

Drug Dependence: 6 people, 20.00%
Insomnia (sleeplessness): 3 people, 10.00%
Immunodeficiency Common Variable: 3 people, 10.00%
Stress And Anxiety: 3 people, 10.00%
Suicide Attempt: 2 people, 6.67%
Somatoform Pain Disorder (a mental disorder characterized by symptoms that suggest pain): 2 people, 6.67%
Alcoholism (problems with alcohol): 2 people, 6.67%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 6.67%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 6.67%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Naltrexone and have Disturbance in attention?

- Check whether Disturbance in attention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Naltrexone:

Naltrexone (4,833 reports)

Browse all side effects of Naltrexone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Disturbance in attention:

Disturbance in attention (1,772 drugs)

Browse all the conditions that are associated with Disturbance in attention:

Disturbance in attention (1,970 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on naltrexone (the active ingredients of Naltrexone) and Naltrexone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.